Granzyme B is a novel interleukin-18 converting enzyme

Journal of Dermatological Science - Tập 59 Số 2 - Trang 129-135 - 2010
Youichi Omoto1, Keiichi Yamanaka1, Kazuya Tokime1, Shigehisa Kitano2, Masato Kakeda1, Tomoko Akeda1, Ichiro Kurokawa1, Osamu Taguchi3, Hiroko Tsutsui4, Naoyuki Katayama2, K Yamanishi5, Kenji Nakanishi6, Hitoshi Mizutani1
1Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Mie 514–8507, Japan
2Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Mie, 514-8507, Japan
3Immunology, Mie University, Graduate School of Medicine, Tsu, Mie 514-8507, Japan
4Department of Microbiology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan.
5Dermatology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan
6Department of Immunology and Medical Zoology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

Nakanishi, 2001, Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu, Cytokine Growth Factor Rev, 12, 53, 10.1016/S1359-6101(00)00015-0

Nakanishi, 2001, Interleukin-18 regulates both Th1 and Th2 responses, Annu Rev Immunol, 19, 423, 10.1146/annurev.immunol.19.1.423

Ghayur, 1997, Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production, Nature, 386, 619, 10.1038/386619a0

Gu, 1997, Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme, Science, 275, 206, 10.1126/science.275.5297.206

Gaggero, 2004, A novel isoform of pro-interleukin-18 expressed in ovarian tumors is resistant to caspase-1 and -4 processing, Oncogene, 23, 7552, 10.1038/sj.onc.1208036

Omoto, 2006, Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment, J Immunol, 177, 8315, 10.4049/jimmunol.177.12.8315

Harris, 1998, Definition and redesign of the extended substrate specificity of granzyme B, J Biol Chem, 273, 27364, 10.1074/jbc.273.42.27364

Waugh, 2000, The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity, Nat Struct Biol, 7, 762, 10.1038/78992

Jenne, 1988, Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation, Immunol Rev, 103, 53, 10.1111/j.1600-065X.1988.tb00749.x

Berke, 1995, Unlocking the secrets of CTL and NK cells, Immunol Today, 16, 343, 10.1016/0167-5699(95)80152-9

Trapani, 2002, Functional significance of the perforin/granzyme cell death pathway, Nat Rev Immunol, 2, 735, 10.1038/nri911

Froelich, 1996, Granzyme B/perforin-mediated apoptosis of Jurkat cells results in cleavage of poly(ADP-ribose) polymerase to the 89-kDa apoptotic fragment and less abundant 64-kDa fragment, Biochem Biophys Res Commun, 227, 658, 10.1006/bbrc.1996.1565

Song, 1996, DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis, EMBO J, 15, 3238, 10.1002/j.1460-2075.1996.tb00688.x

Andrade, 1998, Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis, Immunity, 8, 451, 10.1016/S1074-7613(00)80550-6

Duriez, 1997, Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death, Biochem Cell Biol, 75, 337, 10.1139/o97-043

Graubert, 1996, The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection, Blood, 87, 1232, 10.1182/blood.V87.4.1232.bloodjournal8741232

Park, 2004, Increased expression of IL-18 in cutaneous graft-versus-host disease, Immunol Lett, 95, 57, 10.1016/j.imlet.2004.06.011

Yawalkar, 2001, Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis, Br J Dermatol, 144, 1133, 10.1046/j.1365-2133.2001.04222.x

Yawalkar, 2001, A comparative study of the expression of cytotoxic proteins in allergic contact dermatitis and psoriasis: spongiotic skin lesions in allergic contact dermatitis are highly infiltrated by T cells expressing perforin and granzyme B, Am J Pathol, 158, 803, 10.1016/S0002-9440(10)64027-8

Muller, 1998, Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease, Am J Pathol, 152, 261

Leon, 2009, High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD, Mediat Inflamm, 2009, 580450, 10.1155/2009/580450

Homs, 2009, Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy, Am J Transplant, 9, 1230, 10.1111/j.1600-6143.2009.02596.x

Striz, 2005, Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft, Immunol Lett, 99, 30, 10.1016/j.imlet.2005.01.010

Spaeny-Dekking, 1998, Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo, J Immunol, 160, 3610, 10.4049/jimmunol.160.7.3610

Poe, 1991, Human cytotoxic lymphocyte granzyme B. Its purification from granules and the characterization of substrate and inhibitor specificity, J Biol Chem, 266, 98, 10.1016/S0021-9258(18)52407-8

Talanian, 1996, Stability and oligomeric equilibria of refolded interleukin-1beta converting enzyme, J Biol Chem, 271, 21853, 10.1074/jbc.271.36.21853

Fynbo, 2005, Characterization of a recombinant granzyme B derivative as a “restriction” protease, Protein Expr Purif, 39, 209, 10.1016/j.pep.2004.10.010

Yamin, 1996, Activation of the native 45-kDa precursor form of interleukin-1-converting enzyme, J Biol Chem, 271, 13273, 10.1074/jbc.271.22.13273

Thornberry, 1997, A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis, J Biol Chem, 272, 17907, 10.1074/jbc.272.29.17907

Backes, 2005, GraBCas: a bioinformatics tool for score-based prediction of Caspase- and Granzyme B-cleavage sites in protein sequences, Nucleic Acids Res, 33, W208, 10.1093/nar/gki433

Konishi, 2002, IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions, Proc Natl Acad Sci USA, 99, 11340, 10.1073/pnas.152337799

Yamanaka, 2000, Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18, J Immunol, 165, 997, 10.4049/jimmunol.165.2.997

Yoshimoto, 2000, IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6, Nat Immunol, 1, 132, 10.1038/77811

Mizutani, 1991, Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase, J Exp Med, 174, 821, 10.1084/jem.174.4.821

Mee, 2000, Human keratinocytes constitutively produce but do not process interleukin-18, Br J Dermatol, 143, 330, 10.1046/j.1365-2133.2000.03759.x

Nguyen, 2008, Increased cytotoxicity of CD4+ invariant NKT cells against CD4+CD25hiCD127lo/- regulatory T cells in allergic asthma, Eur J Immunol, 38, 2034, 10.1002/eji.200738082

Reading, 2007, IL-18, but not IL-12, regulates NK cell activity following intranasal herpes simplex virus type 1 infection, J Immunol, 179, 3214, 10.4049/jimmunol.179.5.3214

Hyodo, 1999, IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor, J Immunol, 162, 1662, 10.4049/jimmunol.162.3.1662

Inachi, 1997, Epidermal apoptotic cell death in erythema multiforme and Stevens–Johnson syndrome. Contribution of perforin-positive cell infiltration, Arch Dermatol, 133, 845, 10.1001/archderm.133.7.845

Lauw, 2000, Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria, J Infect Dis, 182, 206, 10.1086/315642

Tak, 1999, The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA), Clin Exp Immunol, 116, 366, 10.1046/j.1365-2249.1999.00881.x

Fujino, 2003, CrmA gene expression protects mice against concanavalin-A-induced hepatitis by inhibiting IL-18 secretion and hepatocyte apoptosis, Gene Ther, 10, 1781, 10.1038/sj.gt.3302067

Miura, 2004, Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand, Biol Blood Marrow Transplant, 10, 156, 10.1016/j.bbmt.2003.10.005

Oberbauer, 2008, Biomarkers—a potential route for improved diagnosis and management of ongoing renal damage, Transplant Proc, 40, S44, 10.1016/j.transproceed.2008.10.005

Ayello, 2009, Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy, Exp Hematol, 37, 1216, 10.1016/j.exphem.2009.07.009

Darmon, 1994, The cytotoxic T cell proteinase granzyme B does not activate interleukin-1 beta-converting enzyme, J Biol Chem, 269, 32043, 10.1016/S0021-9258(18)31596-5

Kerr, 1972, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br J Cancer, 26, 239, 10.1038/bjc.1972.33